Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 3
1993 3
1994 1
1996 1
1997 1
2000 2
2001 1
2002 2
2005 2
2006 1
2007 2
2009 4
2010 2
2011 1
2012 1
2013 2
2015 2
2016 3
2017 3
2018 5
2019 5
2020 13
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

58 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes.
Petrie MC, Verma S, Docherty KF, Inzucchi SE, Anand I, BelohlĆ”vek J, Bƶhm M, Chiang CE, Chopra VK, de Boer RA, Desai AS, Diez M, Drozdz J, DukĆ”t A, Ge J, Howlett J, Katova T, Kitakaze M, Ljungman CEA, Merkely B, Nicolau JC, O'Meara E, Vinh PN, Schou M, Tereshchenko S, KĆøber L, Kosiborod MN, Langkilde AM, Martinez FA, Ponikowski P, Sabatine MS, Sjƶstrand M, Solomon SD, Johanson P, Greasley PJ, Boulton D, Bengtsson O, Jhund PS, McMurray JJV. Petrie MC, et al. Among authors: greasley pj. JAMA. 2020 Apr 14;323(14):1353-1368. doi: 10.1001/jama.2020.1906. JAMA. 2020. PMID: 32219386 Free PMC article. Clinical Trial.
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial.
Cherney DZI, Dekkers CCJ, Barbour SJ, Cattran D, Abdul Gafor AH, Greasley PJ, Laverman GD, Lim SK, Di Tanna GL, Reich HN, Vervloet MG, Wong MG, Gansevoort RT, Heerspink HJL; DIAMOND investigators. Cherney DZI, et al. Among authors: greasley pj. Lancet Diabetes Endocrinol. 2020 Jul;8(7):582-593. doi: 10.1016/S2213-8587(20)30162-5. Lancet Diabetes Endocrinol. 2020. PMID: 32559474 Clinical Trial.
Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF.
Jackson AM, Dewan P, Anand IS, BělohlĆ”vek J, Bengtsson O, de Boer RA, Bƶhm M, Boulton DW, Chopra VK, DeMets DL, Docherty KF, DukĆ”t A, Greasley PJ, Howlett JG, Inzucchi SE, Katova T, KĆøber L, Kosiborod MN, Langkilde AM, Lindholm D, Ljungman CEA, Martinez FA, O'Meara E, Sabatine MS, Sjƶstrand M, Solomon SD, Tereshchenko S, Verma S, Jhund PS, McMurray JJV. Jackson AM, et al. Among authors: greasley pj. Circulation. 2020 Sep 15;142(11):1040-1054. doi: 10.1161/CIRCULATIONAHA.120.047077. Epub 2020 Jul 16. Circulation. 2020. PMID: 32673497 Free PMC article.
Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability.
King AJ, Siegel M, He Y, Nie B, Wang J, Koo-McCoy S, Minassian NA, Jafri Q, Pan D, Kohler J, Kumaraswamy P, Kozuka K, Lewis JG, Dragoli D, Rosenbaum DP, O'Neill D, Plain A, Greasley PJ, Jƶnsson-Rylander AC, Karlsson D, Behrendt M, Strƶmstedt M, Ryden-Bergsten T, Knƶpfel T, Pastor Arroyo EM, Hernando N, Marks J, Donowitz M, Wagner CA, Alexander RT, Caldwell JS. King AJ, et al. Among authors: greasley pj. Sci Transl Med. 2018 Aug 29;10(456):eaam6474. doi: 10.1126/scitranslmed.aam6474. Sci Transl Med. 2018. PMID: 30158152 Free PMC article. Clinical Trial.
The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg E, Larsson N, Sjƶgren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. Ryberg E, et al. Among authors: greasley pj. Br J Pharmacol. 2007 Dec;152(7):1092-101. doi: 10.1038/sj.bjp.0707460. Epub 2007 Sep 17. Br J Pharmacol. 2007. PMID: 17876302 Free PMC article.
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial.
Scholtes RA, Muskiet MHA, van Baar MJB, Hesp AC, Greasley PJ, Karlsson C, Hammarstedt A, Arya N, van Raalte DH, Heerspink HJL. Scholtes RA, et al. Among authors: greasley pj. Diabetes Care. 2021 Feb;44(2):440-447. doi: 10.2337/dc20-2604. Epub 2020 Dec 14. Diabetes Care. 2021. PMID: 33318125 Free PMC article.
Correction of anemia by dapagliflozin in patients with type 2 diabetes.
StefƔnsson BV, Heerspink HJL, Wheeler DC, Sjƶstrƶm CD, Greasley PJ, Sartipy P, Cain V, Correa-Rotter R. StefƔnsson BV, et al. Among authors: greasley pj. J Diabetes Complications. 2020 Dec;34(12):107729. doi: 10.1016/j.jdiacomp.2020.107729. Epub 2020 Sep 5. J Diabetes Complications. 2020. PMID: 32948397
58 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page